Global and China Infliximab and Biosimilar Market Insights, Forecast to 2026

List of Tables
Table 1. Infliximab and Biosimilar Market Segments
Table 2. Ranking of Global Top Infliximab and Biosimilar Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Infliximab and Biosimilar Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Infliximab
Table 5. Major Manufacturers of Infliximab-dyyb
Table 6. Major Manufacturers of Infliximab-abda
Table 7. Global Infliximab and Biosimilar Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Infliximab and Biosimilar Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Infliximab and Biosimilar Sales by Regions 2015-2020 (K Units)
Table 10. Global Infliximab and Biosimilar Sales Market Share by Regions (2015-2020)
Table 11. Global Infliximab and Biosimilar Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Infliximab and Biosimilar Sales Forecast by Region (2021-2026) (K Units)
Table 13. Global Infliximab and Biosimilar Sales by Manufacturers (2015-2020) (K Units)
Table 14. Global Infliximab and Biosimilar Sales Share by Manufacturers (2015-2020)
Table 15. Global Infliximab and Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Infliximab and Biosimilar by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infliximab and Biosimilar as of 2019)
Table 17. Infliximab and Biosimilar Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Infliximab and Biosimilar Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Infliximab and Biosimilar Price (2015-2020) (USD/Unit)
Table 20. Infliximab and Biosimilar Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Infliximab and Biosimilar Product Type
Table 22. Date of International Manufacturers Enter into Infliximab and Biosimilar Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Infliximab and Biosimilar Sales by Type (2015-2020) (K Units)
Table 25. Global Infliximab and Biosimilar Sales Share by Type (2015-2020)
Table 26. Global Infliximab and Biosimilar Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Infliximab and Biosimilar Revenue Share by Type (2015-2020)
Table 28. Infliximab and Biosimilar Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 29. Global Infliximab and Biosimilar Sales Share by Type (2021-2026)
Table 30. Global Infliximab and Biosimilar Sales by Application (2015-2020) (K Units)
Table 31. Global Infliximab and Biosimilar Sales Share by Application (2015-2020)
Table 32. Global Infliximab and Biosimilar Sales Share by Application (2021-2026)
Table 33. Global Infliximab and Biosimilar Sales Market Share Forecast by Application (2021-2026)
Table 34. Global Infliximab and Biosimilar Revenue by Application (2015-2020) (US$ Million)
Table 35. Global Infliximab and Biosimilar Revenue Market Share Forecast by Application (2021-2026)
Table 36. China Infliximab and Biosimilar Sales (K Units) of Key Companies (2015-2020)
Table 37. China Infliximab and Biosimilar Sales Share by Company (2015-2020)
Table 38. China Infliximab and Biosimilar Revenue (US$ Million) by Company (2015-2020)
Table 39. China Infliximab and Biosimilar Sales (K Units) by Type (2015-2020)
Table 40. China Infliximab and Biosimilar Sales Share by Type (2015-2020)
Table 41. China Infliximab and Biosimilar Revenue (US$ Million) Market Share by Type (2015-2020)
Table 42. China Infliximab and Biosimilar Price (K Units) by Type (2015-2020)
Table 43. China Infliximab and Biosimilar Sales (K Units) by Type (2021-2026)
Table 44. China Infliximab and Biosimilar Sales Share by Type (2021-2026)
Table 45. China Infliximab and Biosimilar Revenue (US$ Million) Market Share by Type (2021-2026)
Table 46. China Infliximab and Biosimilar Revenue Share by Type (2021-2026)
Table 47. China Infliximab and Biosimilar Price (K Units) by Type (2021-2026)
Table 48. China Infliximab and Biosimilar Sales (K Units) by Application (2015-2020)
Table 49. China Infliximab and Biosimilar Sales Share by Application (2015-2020)
Table 50. China Infliximab and Biosimilar Revenue (US$ Million) Market Share by Application (2015-2020)
Table 51. China Infliximab and Biosimilar Sales (K Units) by Application (2021-2026)
Table 52. China Infliximab and Biosimilar Sales Share by Application (2021-2026)
Table 53. China Infliximab and Biosimilar Revenue (US$ Million) Market Share by Application (2021-2026)
Table 54. China Infliximab and Biosimilar Revenue Share by Application (2021-2026)
Table 55. North America Infliximab and Biosimilar Sales by Country (2015-2020) (K Units)
Table 56. North America Infliximab and Biosimilar Sales Market Share by Country (2015-2020)
Table 57. North America Infliximab and Biosimilar Revenue by Country (2015-2020) (US$ Million)
Table 58. North America Infliximab and Biosimilar Revenue Market Share by Country (2015-2020)
Table 59. Europe Infliximab and Biosimilar Sales by Country (2015-2020) (K Units)
Table 60. Europe Infliximab and Biosimilar Sales Market Share by Country (2015-2020)
Table 61. Europe Infliximab and Biosimilar Revenue by Country (2015-2020) (US$ Million)
Table 62. Europe Infliximab and Biosimilar Revenue Market Share by Country (2015-2020)
Table 63. Asia Pacific Infliximab and Biosimilar Sales by Region (2015-2020) (K Units)
Table 64. Asia Pacific Infliximab and Biosimilar Sales Market Share by Region (2015-2020)
Table 65. Asia Pacific Infliximab and Biosimilar Revenue by Region (2015-2020) (US$ Million)
Table 66. Asia Pacific Infliximab and Biosimilar Revenue Market Share by Region (2015-2020)
Table 67. Latin America Infliximab and Biosimilar Sales by Country (2015-2020) (K Units)
Table 68. Latin America Infliximab and Biosimilar Sales Market Share by Country (2015-2020)
Table 69. Latin Americaa Infliximab and Biosimilar Revenue by Country (2015-2020) (US$ Million)
Table 70. Latin America Infliximab and Biosimilar Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Infliximab and Biosimilar Sales by Country (2015-2020) (K Units)
Table 72. Middle East and Africa Infliximab and Biosimilar Sales Market Share by Country (2015-2020)
Table 73. Middle East and Africa Infliximab and Biosimilar Revenue by Country (2015-2020) (US$ Million)
Table 74. Middle East and Africa Infliximab and Biosimilar Revenue Market Share by Country (2015-2020)
Table 75. Janssen Biotech Corporation Information
Table 76. Janssen Biotech Description and Business Overview
Table 77. Janssen Biotech Infliximab and Biosimilar Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Janssen Biotech Infliximab and Biosimilar Product
Table 79. Janssen Biotech Recent Development
Table 80. Merck and Co. Corporation Information
Table 81. Merck and Co. Description and Business Overview
Table 82. Merck and Co. Infliximab and Biosimilar Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Merck and Co. Product
Table 84. Merck and Co. Recent Development
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Infliximab and Biosimilar Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Pfizer Product
Table 89. Pfizer Recent Development
Table 90. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 91. Key Challenges
Table 92. Market Risks
Table 93. Main Points Interviewed from Key Infliximab and Biosimilar Players
Table 94. Infliximab and Biosimilar Customers List
Table 95. Infliximab and Biosimilar Distributors List
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Infliximab and Biosimilar Product Picture
Figure 2. Global Infliximab and Biosimilar Sales Market Share by Type in 2020 & 2026
Figure 3. Infliximab Product Picture
Figure 4. Infliximab-dyyb Product Picture
Figure 5. Infliximab-abda Product Picture
Figure 6. Global Infliximab and Biosimilar Sales Market Share by Application in 2020 & 2026
Figure 7. Crohn's Disease
Figure 8. Pediatric Crohn's Disease
Figure 9. Ulcerative Colitis
Figure 10. Rheumatoid Arthritis
Figure 11. Ankylosing Spondylitis
Figure 12. Psoriatic Arthritis
Figure 13. Plaque Psoriasis
Figure 14. Infliximab and Biosimilar Report Years Considered
Figure 15. Global Infliximab and Biosimilar Market Size 2015-2026 (US$ Million)
Figure 16. Global Infliximab and Biosimilar Sales 2015-2026 (K Units)
Figure 17. Global Infliximab and Biosimilar Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Infliximab and Biosimilar Sales Market Share by Region (2015-2020)
Figure 19. Global Infliximab and Biosimilar Sales Market Share by Region in 2019
Figure 20. Global Infliximab and Biosimilar Revenue Market Share by Region (2015-2020)
Figure 21. Global Infliximab and Biosimilar Revenue Market Share by Region in 2019
Figure 22. Global Infliximab and Biosimilar Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Infliximab and Biosimilar Revenue in 2019
Figure 24. Infliximab and Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Infliximab and Biosimilar Sales Market Share by Type (2015-2020)
Figure 26. Global Infliximab and Biosimilar Sales Market Share by Type in 2019
Figure 27. Global Infliximab and Biosimilar Revenue Market Share by Type (2015-2020)
Figure 28. Global Infliximab and Biosimilar Revenue Market Share by Type in 2019
Figure 29. Global Infliximab and Biosimilar Market Share by Price Range (2015-2020)
Figure 30. Global Infliximab and Biosimilar Sales Market Share by Application (2015-2020)
Figure 31. Global Infliximab and Biosimilar Sales Market Share by Application in 2019
Figure 32. Global Infliximab and Biosimilar Revenue Market Share by Application (2015-2020)
Figure 33. Global Infliximab and Biosimilar Revenue Market Share by Application in 2019
Figure 34. China Infliximab and Biosimilar Sales Growth Rate 2015-2026 (K Units)
Figure 35. China Infliximab and Biosimilar Revenue Growth Rate 2015-2026 (US$ Million)
Figure 36. China Infliximab and Biosimilar Market Share in Global Market 2015-2026
Figure 37. China 5 and 10 Largest Infliximab and Biosimilar Players Market Share by Revenue in Infliximab and Biosimilar in 2019
Figure 38. China Infliximab and Biosimilar Revenue Share by Type (2015-2020)
Figure 39. China Infliximab and Biosimilar Revenue Growth Rate by Type in 2015 & 2019
Figure 40. China Infliximab and Biosimilar Revenue Share by Application (2015-2020)
Figure 41. China Infliximab and Biosimilar Revenue Growth Rate by Application in 2015 & 2019
Figure 42. North America Infliximab and Biosimilar Sales Growth Rate 2015-2020 (K Units)
Figure 43. North America Infliximab and Biosimilar Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. North America Infliximab and Biosimilar Sales Market Share by Country in 2019
Figure 45. North America Infliximab and Biosimilar Revenue Market Share by Country in 2019
Figure 46. U.S. Infliximab and Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 47. U.S. Infliximab and Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Canada Infliximab and Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 49. Canada Infliximab and Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Europe Infliximab and Biosimilar Sales Growth Rate 2015-2020 (K Units)
Figure 51. Europe Infliximab and Biosimilar Revenue Growth Rate 2015-2020 (US$ Million)
Figure 52. Europe Infliximab and Biosimilar Sales Market Share by Country in 2019
Figure 53. Europe Infliximab and Biosimilar Revenue Market Share by Country in 2019
Figure 54. Germany Infliximab and Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 55. Germany Infliximab and Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. France Infliximab and Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 57. France Infliximab and Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. U.K. Infliximab and Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 59. U.K. Infliximab and Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Italy Infliximab and Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 61. Italy Infliximab and Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Russia Infliximab and Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 63. Russia Infliximab and Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Asia Pacific Infliximab and Biosimilar Sales Growth Rate 2015-2020 (K Units)
Figure 65. Asia Pacific Infliximab and Biosimilar Revenue Growth Rate 2015-2020 (US$ Million)
Figure 66. Asia Pacific Infliximab and Biosimilar Sales Market Share by Region in 2019
Figure 67. Asia Pacific Infliximab and Biosimilar Revenue Market Share by Region in 2019
Figure 68. China Infliximab and Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 69. China Infliximab and Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Japan Infliximab and Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 71. Japan Infliximab and Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. South Korea Infliximab and Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 73. South Korea Infliximab and Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. India Infliximab and Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 75. India Infliximab and Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Australia Infliximab and Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 77. Australia Infliximab and Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Taiwan Infliximab and Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 79. Taiwan Infliximab and Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Indonesia Infliximab and Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 81. Indonesia Infliximab and Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Thailand Infliximab and Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 83. Thailand Infliximab and Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Malaysia Infliximab and Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 85. Malaysia Infliximab and Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Philippines Infliximab and Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 87. Philippines Infliximab and Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Vietnam Infliximab and Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 89. Vietnam Infliximab and Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Latin America Infliximab and Biosimilar Sales Growth Rate 2015-2020 (K Units)
Figure 91. Latin America Infliximab and Biosimilar Revenue Growth Rate 2015-2020 (US$ Million)
Figure 92. Latin America Infliximab and Biosimilar Sales Market Share by Country in 2019
Figure 93. Latin America Infliximab and Biosimilar Revenue Market Share by Country in 2019
Figure 94. Mexico Infliximab and Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 95. Mexico Infliximab and Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Brazil Infliximab and Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 97. Brazil Infliximab and Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Argentina Infliximab and Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 99. Argentina Infliximab and Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Middle East and Africa Infliximab and Biosimilar Sales Growth Rate 2015-2020 (K Units)
Figure 101. Middle East and Africa Infliximab and Biosimilar Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Infliximab and Biosimilar Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Infliximab and Biosimilar Revenue Market Share by Country in 2019
Figure 104. Turkey Infliximab and Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 105. Turkey Infliximab and Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Infliximab and Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 107. Saudi Arabia Infliximab and Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Infliximab and Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 109. U.A.E Infliximab and Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Porter's Five Forces Analysis
Figure 111. Infliximab and Biosimilar Value Chain
Figure 112. Channels of Distribution
Figure 113. Distributors Profiles
Figure 114. Bottom-up and Top-down Approaches for This Report
Figure 115. Data Triangulation
Figure 116. Key Executives Interviewed